Role of local CpG DNA methylation in mediating the 17q21 asthma susceptibility gasdermin B (GSDMB)/ORMDL sphingolipid biosynthesis regulator 3 (ORMDL3) expression quantitative trait locus - 06/06/18
on behalf of the
Asthma BioRepository for Integrative Genomic Exploration (Asthma BRIDGE) Consortium
Supported by extramural grants from the National Institutes of Health (NIH) through the National Heart, Lung, and Blood Institute (RC2 HL101543 [America Recovery and Reinvestment Act “Grand Opportunity”] and R01 HL086601) and the National Institute of Allergy and Infectious Diseases (T32 AI007306 to P.H.K.). Additional support was provided by the NIH (K01 HL127265 to D.C.C.-C.; P30 ES007048, R01 ES023262, R01 HL061768, R01 ES021801, and P01 ES011627 to F.D.G.; and the Intramural Research Program ZO1 ES49019 to S.J.L.). |
|
Disclosure of potential conflict of interest: D. C. Croteau-Chonka has received a grant from the National Institutes of Health (NIH). F. D. Martinez has received grants from the NIH/National Heart, Lung, and Blood Institute (NHLBI; HL056177, HL132523, HL091889, HL098112, and HL130045), the NIH/National Institute of Environmental Health Sciences (NIEHS; ES006694), the NIH/National Institute of Allergy and Infectious Diseases (NIAID; AI126614), the NIH/Office of the Director (OD023282), and Johnson & Johnson (UA009253-0001) and personal fees from Copeval and Commense. R. F. Lemanske has received grants, payment for writing/reviewing the manuscript, and provision of writing assistance, medicines, equipment, or administrative support from the NHLBI; is a board member for the American Academy of Allergy, Asthma & Immunology; is employed by the University of Wisconsin School of Medicine and Public Health; has received a grant from Pharmaxis; has received payment for lectures from the Asthma and Allergy Foundation of America–Alaska Chapter, the Egyptian Allergy Society, and LSU; and has received royalties from Elsevier and UpToDate. J. A. Krishnan has received a grant from the NIH/NHLBI, has a research contract with the Patient Centered Outcomes Research Institute, has served on the Data Monitoring Committee for Sanofi, and has served on the GINA Science Committee. K. C. Barnes has received a grant from the NIH, royalties from UpToDate, and personal fees from Illumina. S. R. White has received grants from the NHLBI (RC2 HL101543), the NIAID, and the National Center for Advancing Translational Sciences. W. J. Gauderman has received a grant from the NIH. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 141 - N° 6
P. 2282 - juin 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?